Timothy P. Walbert, Chairman, President and CEO at Horizon Therapeutics Public Ltd Co (HZNP), sold 225,000 shares at $90.00 ($20.6M) on 2022-01-28, disclosed to the SEC on 2022-01-31.
Seasonal sale ($20.6M) by Chairman, President and CEO — this insider has traded HZNP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.00 | 25,000 | $2.3M | 10.9% |
| 2 | $90.95 | 14,541 | $1.3M | 6.4% |
| 3 | $90.95 | 14,541 | $1.3M | 6.4% |
| 4 | $91.94 | 74,253 | $6.8M | 33.1% |
| 5 | $91.94 | 74,253 | $6.8M | 33.1% |
| 6 | $92.42 | 11,206 |
| $1.0M |
| 5.0% |
| 7 | $92.42 | 11,206 | $1.0M | 5.0% |
| Total | $91.64 avg | 225,000 | $20.6M | 100% |
| Filing → |
| HZNP | SELL | 2022-05-20 | $2.3M | — | Filing → |
| HZNP | SELL | 2022-05-13 | $1.6M | — | Filing → |
| HZNP | SELL | 2022-05-10 | $672K | — | Filing → |